The pharmaceutical company R-Pharm has obtained regulatory approval for the use of the antiviral drug Coronavir in the treatment of patients suffering from COVID-19.
- Coronavir has been approved in Our Country for the treatment of patients with mild to moderate COVID-19
- “Coronavir is one of the first drugs in Our Country and the world that does not work against complications caused by SARS-CoV-2, but fights directly against the virus itself,” explains R-Pharm.
- Last month, Our Country also temporarily authorized Avifavir to treat COVID-19
Coronavir has been approved in Our Country for the treatment of patients with mild to moderate COVID-19. Clinical trials have shown that the drug is very effective in blocking the replication of SARS-CoV-2 coronavirus.
“Coronavir is one of the first drugs in Our Country and the world that does not work against complications caused by SARS-CoV-2, but fights directly against the virus itself,” explains R-Pharm.
An analysis of clinical trials showed improvement in health in 55 percent. outpatients on the seventh day of treatment, compared to 20 percent. improve health in patients treated with standard therapy. The research results also indicate that on the fifth day of therapy, the absence of the SARS-CoV-2 virus was reported in 77,5% of patients. patients.
In a statement released by R-Pharm, medical director Mikhail Samsonov said global clinical practice and a clinical trial conducted confirmed that Coronavir stops the development of infections much faster by effectively blocking viral replication.
See also: BBC: We may know how to fight COVID-19 in a few months
COVID-19 treatment in Our Country
Last month, Our Country also temporarily authorized the treatment of COVID-19 with the drug Avifavir, which was produced by the Direct Investment Fund (RDIF) and the ChemRar group.
Avifavir has shown efficacy in clinical trials conducted by Moscow Medical University and Moscow Lomonosov University. The clinical trial included 40 patients. Of these, 60 percent. tested negative for the SARS-CoV-2 coronavirus in their blood after five days of treatment. This is twice as fast as with standard therapy.
Avifavir is not only the first antiviral drug registered against coronavirus in Our Country, it is also perhaps the most promising drug against Covid-19 in the world, said RDIF director Kirill Dmitriev.
In Our Country, 707 infections with the SARS-CoV-301 coronavirus have been reported. This is the fourth result in the world. Over the last few days, an average of 6,5 thousand new cases have been recorded in this country. So far 10 people have died and 843 have recovered.
Editors recommend:
- Favipiravir to be the new COVID-19 drug?
- Bergamo Hospital «COVID-19 Free»
- Diseases that may make COVID-19 infection more severe